HomeRNA • NASDAQ
Avidity Biosciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 3.85M | 88.12% |
Operating expense | 36.86M | 77.82% |
Net income | -157.32M | -122.22% |
Net profit margin | -4.09K | -18.13% |
Earnings per share | -1.21 | -86.15% |
EBITDA | -170.33M | -107.87% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.18B | -8.92% |
Total assets | 1.37B | 1.60% |
Total liabilities | 176.26M | 39.46% |
Total equity | 1.19B | — |
Shares outstanding | 128.65M | — |
Price to book | 4.68 | — |
Return on assets | -30.26% | — |
Return on capital | -33.79% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -157.32M | -122.22% |
Cash from operations | -199.67M | -207.16% |
Cash from investing | 185.49M | 167.48% |
Cash from financing | 3.77M | -99.16% |
Net change in cash | -10.29M | -109.63% |
Free cash flow | -54.00M | -32.97% |
Previous close
$46.23
Day range
$45.75 - $47.07
Year range
$21.51 - $55.98
Market cap
5.96B USD
Avg Volume
3.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2012
Website
Employees
391